Molecular cell

SMD2 recognizes RNA modifications to control mRNA processing and support tumor growth

Updated

Abstract

SMD2, a core spliceosomal component, is identified as a direct reader of pseudouridines (ψ) in mRNA.

  • SMD2 preferentially binds to ψ-modified RNA over unmodified uridines in human cells.
  • It collaborates with pseudouridine synthase family enzymes to regulate alternative splicing.
  • SMD2 recognizes ψ residues near exon-intron junctions to influence splicing outcomes.
  • The gene encoding SMD2, SNRPD2, is overexpressed in multiple cancers.
  • SMD2 is essential for tumor cell proliferation by modulating mRNA maturation.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

0 of 9
authors report competing interests
9 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free